欧洲快速诊断测试 (RDT) 市场 – 行业趋势和 2031 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Healthcare Europe Rapid Diagnostic Tests Rdt Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

欧洲快速诊断测试 (RDT) 市场 – 行业趋势和 2031 年预测

  • Healthcare
  • Published Report
  • Feb 2024
  • Europe
  • 350 页面
  • 桌子數： 244
  • 图号： 59
立即购买 立即购买

Europe Rapid Diagnostic Tests Rdt Market

市场规模（十亿美元）

CAGR :  % Diagram

Diagram Forecast Period
 2024 –2031
Diagram Market Size (Base Year)
 USD 12.05 Billion
Diagram Market Size (Forecast Year)
 USD 21.64 Billion
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

欧洲快速诊断测试 (RDT) 市场，按产品类型（消耗品和试剂盒、仪器等）、模式（专业和非处方 [OTC]）、技术（基于 PCR、流通测定、横向流动免疫色谱测定、凝集测定、微流体、底物技术等）、方式（基于实验室的测试和非基于实验室的测试）、年龄组（成人和儿童）、测试类型（确定确认、血清学测试和病毒测序）、方法（体外诊断和分子诊断）、样本（拭子、血液、尿液、唾液、痰液等）、应用（传染病测试、血糖监测、心脏病学测试、肿瘤学测试、心脏代谢测试、药物滥用测试、妊娠和生育测试、毒理学测试等）、最终用户（医院和诊所、诊断实验室、家庭护理环境、研究和学术机构等）、分销渠道（直接招标和零售销售）——行业趋势和预测到 2031 年。

欧洲快速诊断测试 (RDT) 市场

欧洲快速诊断测试 (RDT) 市场分析和见解  

用于诊断慢性传染病（如人类免疫缺陷病毒 ( HIV )、疟疾和其他疾病）的快速诊断检测的兴起推动了市场的增长。缺乏熟练的专业人员导致诊断过程中出现许多事故和错误，预计这将对市场增长构成挑战。

欧洲快速诊断测试 (RDT) 市场欧洲快速诊断测试 (RDT) 市场

Data Bridge Market Research 分析称，欧洲快速诊断测试 (RDT) 市场规模预计将从 2023 年的 120.5 亿美元增至 2031 年的 216.4 亿美元，在 2024 年至 2031 年的预测期内，复合年增长率将达到 8.2%。

报告指标

细节

预测期

2024 至 2031 年

基准年

2023

历史岁月

2022（可定制为 2016 – 2021）

定量单位

收入（十亿美元）

涵盖的领域

产品类型（耗材和试剂盒、仪器等）、模式（专业和非处方 [OTC]）、技术（基于 PCR、流通式检测、横向流动免疫色谱检测、凝集检测、微流体、底物技术等）、方式（实验室检测和非实验室检测）、年龄组（成人和儿童）、检测类型（确定确认、血清学检测和病毒测序）、方法（体外诊断和分子诊断）、样本（拭子、血液、尿液、唾液、痰等）、应用（传染病检测、血糖监测、心脏病学检测、肿瘤学检测、心脏代谢检测、药物滥用检测、妊娠和生育能力检测、毒理学检测等）、最终用户（医院和诊所、诊断实验室、家庭护理环境、研究和学术机构等）、分销渠道（直接招标和零售）

覆盖国家

德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、比利时、荷兰、瑞士和欧洲其他地区

涵盖的市场参与者

雅培 (Abbott)、丹纳赫 (Danaher)、赛莱克斯 (Cellex)、Fujirebio、AdvaCare Pharma、ACCESS BIO、Cardinal Health、Bio-Rad Laboratories, Inc.、Cepheid、BD、F. Hoffmann-La Roche Ltd、bioMérieux SA、InBios International, Inc、Luminex Corporation、Gnomegen LLC、QIAGEN、Quidel Corporation、Inc.、Sysmex Corporation、Cardinal Health、Siemens Healthcare Gmbh、MEGACOR DIAGNOSTIK、PerkinElmer Inc.、Sekisui Diagnostics、PTS Diagnostics、werfen、Nova Biomedical 和 Trinity Biotech 等

市场定义

快速诊断测试比标准诊断测试更受欢迎，因为它们可以在多种情况下（例如败血症、呼吸道感染和脑膜炎）促进对感染的病因分析。目前可用的快速诊断测试并不总是提前阐明，因此它们还不能取代传统测试。快速诊断测试有三种类型。快速免疫测定试纸或盒式磁带用于测量化学物质的浓度。试纸最常用于测试样品中液体的 pH 值，但某些类型的试纸还有其他用途，例如检测污染物的存在。

欧洲快速诊断测试 (RDT) 市场动态

驱动程序

  • 慢性病发病率上升

推动市场增长的因素包括慢性病发病率的上升、老年人口的增加、快速诊断测试的技术发展以及产品发布的增加。然而，预计会制约市场的因素包括快速诊断成本的上升、快速诊断测试面临的产品召回以及对使用快速诊断的认识不足。此外，市场参与者的战略举措和医疗支出的增加也促进了市场的增长。

  • 老年人口感染疾病增加

由于各种因素，包括免疫系统的变化、生活方式以及随着时间的推移，暴露于环境因素，全球老龄化人口面临着罹患慢性和恶性疾病的风险增加。老年人口易患此类健康挑战，这凸显了有效和高效的诊断工具对识别和管理这些疾病的重要性。在这方面，一个值得注意的方面是老年人中非特异性抗体的普遍存在，这使得特定疾病的检测更具挑战性。

欧洲快速诊断测试 (RDT) 市场

机会

  • 市场参与者的战略启动和产品发布

市场正在经历一个显著的趋势，即新产品和新产品的推出不断增加。创新的激增凸显了诊断领域的动态性，各公司积极推出新颖的解决方案来满足不断变化的医疗保健需求。对准确、快速诊断工具的需求不断增长，特别是在人口老龄化的背景下，这刺激了研发投资的增加。

限制/挑战

  • 快速诊断试剂盒成本高昂

由于深入研究和有效性，快速诊断试剂盒的成本有所上升。然而，所用材料的价格以及治疗和服务的发展将增加制造单位的数量，并需要更多的劳动力和人力资源来诊断和筛查病原体活力。

快速诊断开发成本高昂，需要适当的协议采购策略。然而，由于经济实力低下，专科诊所和诊断实验室在购买检测设备时面临障碍，这将限制检测试剂盒及其配件的销售。

  • 严格的市场审批规定

这些法规涵盖快速诊断测试的各个方面，例如体外诊断和分子诊断。这些规则和法规是市场批准所必需的，以确保患者的安全。

获得这些法律手续的监管批准可能需要大量的财务支出，可能需要数月或数年才能完成。如果不了解或不考虑这些限制，在竞争激烈的市场中取得成功的可能性可能会因延误而大大降低，预计这将对市场增长构成挑战。

最新动态

  •  2023 年 5 月，F. HOFFMANN-LA ROCHE LTD 正式宣布收购 Stratos Genomics。此次收购促成了用于诊断的 DNA 测序的发展。这增强了公司的医疗诊断部门，从而为公司带来了更多收入
  • 2023 年 4 月，7 月，bioMérieux SA 的 BIOFIRE Respiratory Panel 2.1 plus 检测试剂盒可检测 23 种病原体，包括 SARS-CoV-2 感染，这些病原体是导致呼吸道感染的罪魁祸首，可在世界各地商业化使用，有助于早期诊断呼吸道感染。这一进展帮助公司创造了更多收入

欧洲快速诊断测试 (RDT) 市场范围

欧洲快速诊断测试 (RDT) 市场根据产品类型、模式、技术、方式、年龄组、测试类型、方法、样本、应用、最终用户和分销渠道分为 11 个值得关注的细分市场。这些细分市场之间的增长将帮助您分析行业中的主要增长细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。

 产品类型

  • 仪器
  • 耗材和套件
  • 其他的

根据产品类型，市场分为消耗品和套件、仪器和其他。

模式

  • 场外交易 [OTC]
  • 专业的

根据模式，市场分为专业市场和非处方药 [OTC] 市场。

 技术

  • 基于PCR
  • 流通分析
  • 横向流动免疫层析检测
  • 微流体
  • 基板技术
  • 凝集试验
  • 其他的

根据技术，市场细分为基于 PCR 的流通分析、侧流免疫色谱分析、凝集分析、微流体、底物技术等。

情态

  • 实验室测试
  • 非实验室测试

根据方式，市场分为基于实验室的测试和非基于实验室的测试。

年龄组

  • 儿科
  • 成人

根据年龄组，市场分为成人和儿童。

测试类型

  • 确定确认
  • 血清学检测
  • 病毒测序

根据测试类型，市场分为确定确认、血清学测试和病毒测序。

方法

  • 分子诊断
  • 体外诊断

根据方法，市场分为体外诊断和分子诊断。

标本

  • 拭子
  • 血
  • 尿
  • 唾液
  • 痰
  • 其他的

 根据样本，市场分为拭子、血液、尿液、唾液、痰液和其他。

应用

  • 传染病检测
  • 心脏病学检查
  • 肿瘤学检测
  • 妊娠及生育测试
  • 毒理学测试
  • 药物滥用检测
  • 心脏代谢测试
  • 血糖监测
  • 其他的

根据应用，市场分为传染病检测、血糖监测、心脏病学检测、肿瘤学检测、心脏代谢检测、药物滥用检测、妊娠和生育能力测试、毒理学测试等。

最终用户

  • 医院和诊所
  • 诊断实验室
  • 家庭护理环境
  • 研究与学术机构
  • 其他的

根据最终用户，市场分为医院和诊所、诊断实验室、家庭护理机构、研究和学术机构等。

分销渠道

  • 直接招标
  • 零售销售

根据分销渠道，市场分为直接招标和零售。

欧洲快速诊断测试 (RDT) 市场

区域分析：欧洲快速诊断测试 (RDT) 市场

对欧洲快速诊断测试 (RDT) 市场进行分析，并提供市场规模信息，包括产品类型、模式、技术、方式、年龄组、测试类型、方法、样本、应用、最终用户和分销渠道。

欧洲快速诊断测试 (RDT) 市场报告涵盖的国家包括德国、法国、英国、意大利、西班牙、俄罗斯、土耳其、比利时、荷兰、瑞士和欧洲其他国家。 

由于主要市场参与者的存在和欧洲快速诊断测试在该地区的技术进步，预计德国将在市场上占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了欧洲品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。  

欧洲快速诊断测试 (RDT) 市场：竞争格局和份额分析

欧洲快速诊断测试 (RDT) 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对欧洲快速诊断测试市场的关注有关。

欧洲快速诊断测试 (RDT) 市场的主要供应商包括 Abbott、Danaher、Cellex、Fujirebio、Pharma、Access Bio、Cardinal Health、Bio-Rad Laboratories, Inc.、BD、F. Hoffmann-La Roche Ltd、BIOMÉRIEUX SA、InBios International, Inc、Luminex Corporation. A DiaSorin Company、Gnomegen LLC、QIAGEN、Quidel Corporation、Sysmex Europe Gmbh（Sysmex Corporation 的子公司）、Cardinal Health、Siemens Healthcare Gmbh（Siemens Healthineers AG 的子公司）、MEGACOR DIAGNOSTIK GMBH、PerkinElmer Inc.、Sekisui Diagnostics、PTS Diagnostics、werfen、Nova Biomedical 和 Trinity Biotech 等。    

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE RAPID DIAGNOSTIC TESTS (RTD) MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE SEGMENT LIFELINE CURVE

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.1 MARKET APPLICATION COVERAGE GRID

2.11 SECONDARY SOURCES

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASE IN INCIDENCE OF CHRONIC DISEASES

5.1.2 RISE IN GERIATRIC POPULATION OF THE INFECTIOUS DISEASES

5.1.3 TECHNOLOGICAL ADVANCEMENTS IN RAPID DIAGNOSTIC TESTING

5.1.4 GOVERNMENT INITIATIVES FOR DIAGNOSIS OF INFECTIOUS DISEASES

5.2 RESTRAINTS

5.2.1 HIGH COST ASSOCIATED WITH THE RAPID DIAGNOSTIC KITS

5.2.2 PRODUCT RECALLS IN RAPID DIAGNOSTIC TESTS

5.2.3 LACK OF AWARENESS ABOUT RAPID DIAGNOSTIC TESTING OF THE DISEASES

5.3 OPPORTUNITIES

5.3.1 STRATEGIC INITIATION AND PRODUCT LAUNCHES BY MARKET PLAYERS

5.3.2 RISE IN GOVERNMENT SUPPORT AND FUNDING FOR RAPID DIAGNOSTIC TEST

5.3.3 INCREASING AWARENESS ABOUT THE PROMPT AND EFFICIENT DIAGNOSIS

4.1 CHALLENGES

5.3.4 STRINGENT REGULATORY FOR MARKET APPROVAL

5.3.5 LACK OF TRAINING AND EXPERTISE IN THE DIAGNOSTIC CENTRES

6 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 CONSUMABLES AND KITS

6.2.1 RAPID IMMUNOASSAY TEST STRIPS/CASSETTES

6.2.2 IMMUNOCHROMATOGRAPHIC ASSAY

6.2.2.1 ANTIBODY TESTS

6.2.2.1.1 TOTAL ANTIBODY ELISA KIT

6.2.2.1.2 IGM/IGG RAPID DIAGNOSTIC TEST

6.2.2.1.3 IGG ELISA KIT

6.2.2.1.4 IGM ELISA KIT

6.2.2.1.5 NEUTRALIZING ANTIBODY ELISA KIT

6.2.3 ANTIGEN ELISA KITS

6.2.4 SPECIMEN COLLECTION KIT

6.3 RT-PCR ASSAY KITS

6.3.1 REVERSE TRANSCRIPTION PCR (RT-PCR)

6.3.2 QUANTITATIVE REVERSE TRANSCRIPTION PCR (RT-QPCR)

6.3.3 OTHERS

6.4 INSTRUMENTS

6.4.1 PORTABLE

6.4.2 BENCHTOP

6.4.3 FIXED

6.5 OTHERS

7 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE

7.1 OVERVIEW

7.2 PROFESSIONAL

7.3 OVER-THE-COUNTER [OTC]

8 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY

8.1 OVERVIEW

8.2 PCR-BASED

8.3 FLOW-THROUGH ASSAYS

8.4 LATERAL FLOW IMMUNOCHROMATOGRAPHIC ASSAYS

8.5 AGGLUTINATION ASSAY

 

8.6 MICROFLUIDICS

8.6.1 PAPER-BASED MICROFLUDICS

8.6.2 LUCIFERASE IMMUNOPRECIPITATION SYSTEMS (LIPS)

8.6.3 OTHERS

8.7 SUBSTRATE TECHNOLOGY

8.8 OTHERS

9 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY

9.1 OVERVIEW

9.2 LABORATORY BASED TEST

9.3 NON-LABORATORY BASED TEST

10 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP

10.1 OVERVIEW

10.2 ADULT

10.3 PEDIATRIC

11 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE

11.1 OVERVIEW

11.2 DETERMINING CONFIRMATION

11.2.1 RT-PCR ASSAY KITS

11.2.2 RAPID IMMUNOASSAY TEST STRIPS/CASSETTES

11.2.3 IMMUNOCHROMATOGRAPHIC ASSAY

11.2.4 OTHERS

11.3 SEROLOGICAL TESTING

11.3.1 RT-PCR ASSAY KITS

11.3.2 RAPID IMMUNOASSAY TEST STRIPS/CASSETTES

11.3.3 IMMUNOCHROMATOGRAPHIC ASSAY

11.3.4 OTHERS

11.4 VIRAL SEQUENCING

11.4.1 RT-PCR ASSAY KITS

11.4.2 RAPID IMMUNOASSAY TEST STRIPS/CASSETTES

11.4.3 IMMUNOCHROMATOGRAPHIC ASSAY

11.4.4 OTHERS

12 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH

12.1 OVERVIEW

12.2 IN-VITRO DIAGNOSTIC

12.3 MOLECULAR DIAGNOSTIC

 

13 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN

13.1 OVERVIEW

13.2 SWAB

13.3 BLOOD

13.4 URINE

13.5 SALIVA

13.6 SPUTUM

13.7 OTHERS

14 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION

14.1 OVERVIEW

14.2 INFECTIOUS DISEASE TESTING

14.2.1 VIRUS

14.2.2 BACTERIA

14.2.3 OTHERS

14.3 GLUCOSE MONITORING

14.4 CARDIOLOGY TESTING

14.5 ONCOLOGY TESTING

14.5.1 LUNG CANCER

14.5.2 BREAST CANCER

14.5.3 BLOOD CANCER

14.5.4 OTHERS

14.6 CARDIOMETABOLIC TESTING

14.7 DRUGS-OF-ABUSE TESTING

14.8 PREGNANCY & FERTILITY TESTING

14.9 TOXICOLOGY TESTING

14.1 OTHERS

15 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER

15.1 OVERVIEW

15.2 HOSPITAL & CLINIC

15.3 DIAGNOSTIC LABORATORY

15.4 HOME CARE SETTING

15.5 RESEARCH AND ACADEMIC INSTITUTES

15.6 OTHERS

16 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL

16.1 OVERVIEW

16.2 DIRECT TENDER

16.3 RETAIL SALES

17 EUROPE BY COUNTRY

17.1 OVERVIEW

17.1.1 GERMANY

17.1.2 FRANCE

17.1.3 U.K.

17.1.4 ITALY

17.1.5 SPAIN

17.1.6 RUSSIA

17.1.7 TURKEY

17.1.8 BELGIUM

17.1.9 NETHERLANDS

17.1.10 SWITZERLAND

17.1.11 REST OF EUROPE

18 EUROPE RAPID DIAGNOSTICS TESTS (RDT) MARKET: COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: EUROPE

19 SWOT ANALYSIS

20 COMPANY PROFILES

20.1 ABBOTT

20.1.1 COMPANY SNAPSHOT

20.1.2 REVENUE ANALYSIS

20.1.3 PRODUCT PORTFOLIO

20.1.4 RECENT DEVELOPMENTS

20.2 F. HOFFMANN-LA ROCHE LTD

20.2.1 COMPANY SNAPSHOT

20.2.2 REVENUE ANALYSIS

20.2.3 PRODUCT PORTFOLIO

20.2.4 RECENT DEVELOPMENTS

20.3 SIEMENS HEALTHCARE GMBH (A SUBSIDIARY OF SIEMENS HEALTHINEERS AG)

20.3.1 COMPANY SNAPSHOT

20.3.2 REVENUE ANALYSIS

20.3.3 PRODUCT PORTFOLIO

20.3.4 RECENT DEVELOPMENTS

20.4 PTS DIAGNOSTICS

20.4.1 COMPANY SNAPSHOT

20.4.2 PRODUCT PORTFOLIO

20.4.3 RECENT DEVELOPMENTS

 

20.5 CARDINAL HEALTH

20.5.1 COMPANY SNAPSHOT

20.5.2 REVENUE ANALYSIS

20.5.3 PRODUCT PORTFOLIO

20.5.4 RECENT DEVELOPMENT

20.6 ACCESS BIO

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENTS

20.7 BD

20.7.1 COMPANY SNAPSHOT

20.7.2 REVENUE ANALYSIS

20.7.3 PRODUCT PORTFOLIO

20.7.4 RECENT DEVELOPMENTS

20.8 BIOMÉRIEUX SA

20.8.1 COMPANY SNAPSHOT

20.8.2 REVENUE ANALYSIS

20.8.3 PRODUCT PORTFOLIO

20.8.4 RECENT DEVELOPMENT

20.9 BIO-RAD LABORATORIES, INC.

20.9.1 COMPANY SNAPSHOT

20.9.2 REVENUE ANALYSIS

20.9.3 PRODUCT PORTFOLIO

20.9.4 RECENT DEVELOPMENTS

20.1 CELLEX

20.10.1 COMPANY SNAPSHOT

20.10.2 PRODUCT PORTFOLIO

20.10.3 RECENT DEVELOPMENTS

20.11 DANAHER

20.11.1 COMPANY SNAPSHOT

20.11.2 REVENUE ANALYSIS

20.11.3 PRODUCT PORTFOLIO

20.11.4 RECENT DEVELOPMENTS

20.12 FUJIREBIO (A SUBSIDIARY OF H.U. GROUP)

20.12.1 COMPANY SNAPSHOT

20.12.2 PRODUCT PORTFOLIO

20.12.3 RECENT DEVELOPMENTS

 

20.13 GNOMEGAN LLC

20.13.1 COMPANY SNAPSHOT

20.13.2 PRODUCT PORTFOLIO

20.13.3 RECENT DEVELOPMENT

20.14 INBIOS INTERNATIONAL, INC

20.14.1 COMPANY SNAPSHOT

20.14.2 PRODUCT PORTFOLIO

20.14.3 RECENT DEVELOPMENTS

20.15 LUMINEX CORPORATION, A DIASORIN COMPANY

20.15.1 COMPANY SNAPSHOT

20.15.2 PRODUCT PORTFOLIO

20.15.3 RECENT DEVELOPMENT

20.16 MEGAKOR DIAGNOSTIK GMBH

20.16.1 COMPANY SNAPSHOT

20.16.2 PRODUCT PORTFOLIO

20.16.3 RECENT DEVELOPMENT

20.17 NOVA BIOMEDICAL

20.17.1 COMPANY SNAPSHOT

20.17.2 PRODUCT PORTFOLIO

20.17.3 RECENT DEVELOPMENTS

20.18 PERKIN ELMER INC.

20.18.1 COMPANY SNAPSHOT

20.18.2 REVENUE ANALYSIS

20.18.3 PRODUCT PORTFOLIO

20.18.4 RECENT DEVELOPMENTS

20.19 QIAGEN

20.19.1 COMPANY SNAPSHOT

20.19.2 REVENUE ANALYSIS

20.19.3 PRODUCT PORTFOLIO

20.19.4 RECENT DEVELOPMENT

20.2 QUIDEL CORPORATION

20.20.1 COMPANY SNAPSHOT

20.20.2 REVENUE ANALYSIS

20.20.3 PRODUCT PORTFOLIO

20.20.4 RECENT DEVELOPMENTS

20.21 SEKISUI DIAGNOSTICS

20.21.1 COMPANY SNAPSHOT

20.21.2 PRODUCT PORTFOLIO

20.21.3 RECENT DEVELOPMENTS

 

20.22 SYSMEX EUROPE GMBH (A SUBSIDIARY OF SYSMEX CORPORATION)

20.22.1 COMPANY SNAPSHOT

20.22.2 REVENUE ANALYSIS

20.22.3 PRODUCT PORTFOLIO

20.22.4 RECENT DEVELOPMENTS

20.23 TRINITY BIOTECH

20.23.1 COMPANY SNAPSHOT

20.23.2 REVENUE ANALYSIS

20.23.3 PRODUCT PORTFOLIO

20.23.4 RECENT DEVELOPMENT

20.24 WERFEN

20.24.1 COMPANY SNAPSHOT

20.24.2 PRODUCT PORTFOLIO

20.24.3 RECENT DEVELOPMENT

21 QUESTIONNAIRE

22 RELATED REPORTS

表格列表

TABLE 1 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 2 EUROPE CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 3 EUROPE IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 4 EUROPE ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 5 EUROPE RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 6 EUROPE INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 7 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 8 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 9 EUROPE MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 10 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 11 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 12 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 13 EUROPE DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 14 EUROPE SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 15 EUROPE VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 16 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 17 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 18 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 19 EUROPE INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 20 EUROPE ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 21 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 22 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 23 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 24 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 25 GERMANY CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 26 GERMANY IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 27 GERMANY ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 28 GERMANY RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 29 GERMANY INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 30 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 31 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 32 GERMANY MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 33 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 34 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 35 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 36 GERMANY DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 37 GERMANY SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 38 GERMANY VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 39 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 40 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 41 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 42 GERMANY INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 43 GERMANY ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 44 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 45 GERMANY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 46 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 47 FRANCE CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 48 FRANCE IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 49 FRANCE IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 50 FRANCE RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 51 FRANCE INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 52 FRANCE INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 53 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 54 FRANCE MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 55 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 56 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 57 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 58 FRANCE DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 59 FRANCE SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 60 FRANCE VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 61 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 62 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 63 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 64 FRANCE INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 65 FRANCE ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 66 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 67 FRANCE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 68 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 69 U.K. CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 70 U.K. IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 71 U.K. ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 72 U.K. RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 73 U.K. INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 74 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 75 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 76 U.K. MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 77 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 78 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 79 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 80 U.K. DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 81 U.K. SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 82 U.K. VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 83 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 84 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 85 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 86 U.K. INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 87 U.K. ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 88 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 89 U.K. RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 90 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 91 ITALY CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 92 ITALY IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 93 ITALY ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 94 ITALY RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 95 ITALY INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 96 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 97 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 98 ITALY MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 99 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 100 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 101 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 102 ITALY DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 103 ITALY SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 104 ITALY VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 105 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 106 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 107 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 108 ITALY INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 109 ITALY ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 110 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 111 ITALY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 112 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 113 SPAIN CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 114 SPAIN IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 115 SPAIN ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 116 SPAIN RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 117 SPAIN INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 118 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 119 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 120 SPAIN MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 121 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 122 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 123 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 124 SPAIN DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 125 SPAIN SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 126 SPAIN VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 127 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 128 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 129 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 130 SPAIN INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 131 SPAIN ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 132 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 133 SPAIN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 134 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 135 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 136 RUSSIA IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 137 RUSSIA ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 138 RUSSIA RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 139 RUSSIA INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 140 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 141 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 142 RUSSIA MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 143 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 144 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 145 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 146 RUSSIA DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 147 RUSSIA SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 148 RUSSIA VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 149 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 150 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 151 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 152 RUSSIA INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 153 RUSSIA ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 154 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 155 RUSSIA RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 156 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 157 TURKEY CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 158 TURKEY IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 159 TURKEY ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 160 TURKEY RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 161 TURKEY INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 162 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 163 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 164 TURKEY MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 165 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 166 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 167 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 168 TURKEY DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 169 TURKEY SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 170 TURKEY VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 171 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 172 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 173 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 174 TURKEY INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 175 TURKEY ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 176 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 177 TURKEY RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 178 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 179 BELGIUM CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 180 BELGIUM IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 181 BELGIUM ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 182 BELGIUM RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 183 BELGIUM INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 184 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 185 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 186 BELGIUM MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 187 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 188 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 189 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 190 BELGIUM DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 191 BELGIUM SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 192 BELGIUM VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 193 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROCH, 2022-2031 (USD MILLION)

TABLE 194 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 195 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 196 BELGIUM INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 197 BELGIUM ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 198 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 199 BELGIUM RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 200 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 201 NETHERLANDS CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 202 NETHERLANDS IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 203 NETHERLANDS ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 204 NETHERLANDS RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 205 NETHERLANDS INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 206 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 207 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 208 NETHERLANDS MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 209 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 210 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 211 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 212 NETHERLANDS DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 213 NETHERLANDS SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 214 NETHERLANDS VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 215 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROCH, 2022-2031 (USD MILLION)

TABLE 216 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 217 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 218 NETHERLANDS INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 219 NETHERLANDS ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 220 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 221 NETHERLANDS RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 222 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 223 SWITZERLAND CONSUMABLES AND KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 224 SWITZERLAND IMMUNOCHROMATOGRAPHIC ASSAY IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 225 SWITZERLAND ANTIBODY TESTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 226 SWITZERLAND RT-PCR ASSAY KITS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 227 SWITZERLAND INSTRUMENTS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

TABLE 228 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODE, 2022-2031 (USD MILLION)

TABLE 229 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 230 SWITZERLAND MICROFLUIDICS IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TECHNOLOGY, 2022-2031 (USD MILLION)

TABLE 231 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY MODALITY, 2022-2031 (USD MILLION)

TABLE 232 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY AGE GROUP, 2022-2031 (USD MILLION)

TABLE 233 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 234 SWITZERLAND DETERMINING CONFIRMATION IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 235 SWITZERLAND SEROLOGICAL TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 236 SWITZERLAND VIRAL SEQUENCING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY TEST TYPE, 2022-2031 (USD MILLION)

TABLE 237 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPROACH, 2022-2031 (USD MILLION)

TABLE 238 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY SPECIMEN, 2022-2031 (USD MILLION)

TABLE 239 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 240 SWITZERLAND INFECTIOUS DISEASE TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 241 SWITZERLAND ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 242 SWITZERLAND ONCOLOGY TESTING IN RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY END USER, 2022-2031 (USD MILLION)

TABLE 243 SWITZERLAND RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 244 REST OF EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)

图片列表

FIGURE 1 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: SEGMENTATION

FIGURE 2 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: DROC ANALYSIS

FIGURE 4 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE RAPID DIAGNOSTIC TESTS (RTD) MARKET: DBMR POSITION GRID

FIGURE 8 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: APPLICATION COVERAGE GRID

FIGURE 10 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: SEGMENTATION

FIGURE 11 THE INCREASED BURDEN OF INFECTIOUS DISEASES, RISE IN AWARENESS OF RAPID DIAGNOSTIC TESTS, AND RISE IN PRODUCT LAUNCHES ARE DRIVING THE GROWTH OF THE EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET FROM 2024 TO 2031

FIGURE 12 CONSUMABLES AND KITS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET FROM 2024 TO 2031

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE RAPID DIAGNOSTIC TESTS (RTD) MARKET

FIGURE 14 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY PRODUCT TYPE, 2023

FIGURE 15 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)

FIGURE 16 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY PRODUCT TYPE, CAGR (2024-2031)

FIGURE 17 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 18 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODE, 2023

FIGURE 19 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODE, 2024-2031 (USD MILLION)

FIGURE 20 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODE, CAGR (2024-2031)

FIGURE 21 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODE, LIFELINE CURVE

FIGURE 22 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TECHNOLOGY, 2023

FIGURE 23 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TECHNOLOGY, 2024-2031 (USD MILLION)

FIGURE 24 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TECHNOLOGY, CAGR (2024-2031)

FIGURE 25 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TECHNOLOGY, LIFELINE CURVE

FIGURE 26 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODALITY, 2023

FIGURE 27 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODALITY, 2024-2031 (USD MILLION)

FIGURE 28 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODALITY, CAGR (2024-2031)

FIGURE 29 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY MODALITY, LIFELINE CURVE

FIGURE 30 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY AGE GROUP, 2023

FIGURE 31 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY AGE GROUP, 2024-2031 (USD MILLION)

FIGURE 32 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY AGE GROUP, CAGR (2024-2031)

FIGURE 33 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 34 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TEST TYPE, 2023

FIGURE 35 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TEST TYPE, 2024-2031 (USD MILLION)

FIGURE 36 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TEST TYPE, CAGR (2024-2031)

FIGURE 37 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY TEST TYPE, LIFELINE CURVE

FIGURE 38 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY APPROACH, 2023

FIGURE 39 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY APPROACH, 2024-2031 (USD MILLION)

FIGURE 40 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY APPROACH, CAGR (2024-2031)

FIGURE 41 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY APPROACH, LIFELINE CURVE

FIGURE 42 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY SPECIMEN, 2023

FIGURE 43 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY SPECIMEN, 2024-2031 (USD MILLION)

FIGURE 44 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY SPECIMEN, CAGR (2024-2031)

FIGURE 45 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY SPECIMEN, LIFELINE CURVE

FIGURE 46 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY APPLICATION, 2023

FIGURE 47 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY APPLICATION, 2024-2031 (USD MILLION)

FIGURE 48 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 49 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 50 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY END USER, 2023

FIGURE 51 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 52 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY END USER, CAGR (2024-2031)

FIGURE 53 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: BY END USER, LIFELINE CURVE

FIGURE 54 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 55 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)

FIGURE 56 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 57 EUROPE RAPID DIAGNOSTIC TESTS (RDT)MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 58 EUROPE RAPID DIAGNOSTIC TESTS (RDT) MARKET: SNAPSHOT (2023)

FIGURE 59 EUROPE RAPID DIAGNOSTICS TESTS (RDT) MARKET: COMPANY SHARE 2023 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The rapid diagnostic tests (RDT) industry was worth USD 12.05 billion in 2023 & it is projected to reach USD 21.64 billion by 2031.
The growth rate of the Europe rapid diagnostic tests (RDT) market is 8.2%.
Increase in the incidence of chronic diseases & rise in geriatric population of the infectious diseases are the growth drivers of the Europe rapid diagnostic tests (RDT) market.
Product type, mode, technology, modality, age group, test type, approach, specimen, application, end user, and distribution channel are the factors on which the Europe rapid diagnostic tests (RDT) market research is based.
Major companies in the Europe rapid diagnostic tests (RDT) market are Abbott, Danaher, Cellex, Fujirebio, AdvaCare Pharma, ACCESS BIO, Cardinal Health, Bio-Rad Laboratories, Inc., Cepheid, BD, F. Hoffmann-La Roche Ltd, bioMérieux SA, InBios International, Inc, Luminex Corporation, Gnomegen LLC, QIAGEN, Quidel Corporation, , Inc., Sysmex Corporation, Cardinal Health, Siemens Healthcare Gmbh, MEGACOR DIAGNOSTIK, PerkinElmer Inc., Sekisui Diagnostics, PTS Diagnostics, werfen, Nova Biomedical, and Trinity Biotech among others.

浏览相关页面

Banner